Product Code: RP-ID-10307122 |
Published Date: 21 Oct 2022 |
Region: NA |
Category: Healthcare & Pharmaceuticals |
Report ID: 10307122
Market Overview:
Parkinson's Disease Treatment Market Share, Size, Trends, & Industry Analysis Report 2019-2026
The global parkinson’s disease treatment market is expected to witness significant growth over the forecast period. Increasing prevalence of Parkinson's disease is expected to accelerate the growth of this industry in near future. Additionally, combination treatments which aids in prolonged action of unremitting dopaminergic stimulation medicines, gene therapy and neural transplantation is anticipated to boost the industry growth.
Parkinson’s is a neurodegenerative disease which primarily affects the human brain parts, making it difficult for the person to function or perform daily routine. People suffering from Parkinson’s cannot produce enough dopamine, which leads to stiffness, tremors, walking problems among others. This disease can become severe if not treated on time. This severity can result in increasing demand for Parkinson’s disease treatment
Scope of the Report
The Parkinson’s disease drugs market has been segmented by mechanism of action and geography. By mechanism of action, the market studied is segmented into dopamine agonists, anticholinergic, MAO-B inhibitors, amantadine, carbidopa-levodopa, COMT inhibitors, and others.
Market Segmentation
Parkinson’s disease Treatment Market, By Type
*Dopamine Agonists
*Levodopa
*Glutamate Antagonist
*Apomorphine
*COMT Inhibitors Anticholinergics
*MAO-B Inhibitors
By Application
*Hospitals
*Healthcare Institutes
*Others
By Regional Ananlysis
North America
*U.S.
*Canada
Europe
*Germany
*UK
*France
*Italy
*Spain
*Belgium
*Russia
*Netherlands
*Rest of Europe
Asia-Pacific
*China
*India
*Japan
*Korea
*Singapore
*Malaysia
*Indonesia
*Thailand
*Philippines
*Rest of Asia-Pacific
Latin America
*Brazil
*Mexico
*Argentina
*Rest of LATAM
Middle East & Africa
*UAE
*Saudi Arabia
*South Africa
*Rest of MEA
Global Parkinson's Disease Treatment Market: Competitive Players
Some of the most important market players in the Parkinson’s disease treatment market are Salix Pharmaceuticals, GlaxoSmithKline Plc., Teva Pharmaceutical Industries Ltd., Impax Laboratories, Inc., Orion Corporation, Novartis AG, Par Pharmaceutical, Mylan N.V., Daiichi Sankyo, Cipla Inc., Wockhardt Limited, and Apotex Inc., among others.
Related Reports
Proof of Quality & Reliability
